
|Articles|March 1, 2002
PC-SPES not as beneficial for androgen-dependent PCa
New York-Some prostate cancer patients may be running to the healthfood store for supplements like PC-SPES, but the supplement cannot competewith other tried and true hormonal therapies, at least in men with androgen-dependentdisease, according to William Oh, MD.
Advertisement
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves sildenafil oral film for men with erectile dysfunction
2
The UroOnc Minute: Adjuvant Therapy in Renal Cell Carcinoma, with Brian Shuch, MD
3
Head-to-head analysis shows OS benefit with apalutamide vs darolutamide in mCSPC
4
URO-1 prostate biopsy devices adopted across Novant Health System as clinical study continues
5






